Mark E. Taafel, PA

Mark Taafel practices at American Family Care New Britain in New Britain, Connecticut.

Mark Taafel's NPI, 1912923889, was assigned on July 14, 2006. Mark Taafel holds Connecticut license 000225.

Mark Taafel's primary practice is American Family Care New Britain, at 135 E Main St, New Britain, CT 06051. The practice phone is (860) 357-6899.

Mark Taafel's primary practice is American Family Care New Britain in New Britain, Connecticut. The medical group on file is AFC Urgent Care Danbury. Dmand AI also links Mark Taafel to 1 more group practice or clinic, named with a free account. Mark Taafel's employer is on file too: an urgent care center.

Dmand AI tracks the electronic health record (EHR) system at each site where Mark Taafel practices, 2 sites in all. Vendor and product names are available with a free account.

Medical is Mark Taafel's primary specialty in the NPI Registry, under taxonomy code 363AM0700X. Mark Taafel is board certified in 2019 - 2022 by the CA State PA License. Mark Taafel is licensed in Connecticut.

Dmand AI lists acute sinusitis, acute skin infection, ankle or foot injury, broken or dislocated ankle/ or foot, bronchitis, chronic nasal allergies, conjunctivitis and contact dermatitis among the conditions Mark Taafel treats.

CMS data shows 155 Medicare services from Mark Taafel across 7 procedure codes in 2024, for 101 Medicare patients. Medicare paid $9,576 for them. Every service was in an office.

CMS counts 101 Medicare patients who saw Mark Taafel in 2024. The largest group is 65 to 74, with 47 patients. 69% of them have high cholesterol, and 57% have high blood pressure. 29% are also on Medicaid. Their average risk score is 1.14, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Mark Taafel's median patient age at 37, with 61% women.

In 2024, Mark Taafel wrote 213 Medicare Part D claims for 159 patients. 92% of them were for generic drugs. CMS names the drug for 102 of them, across 6 drugs with 11 or more claims each, at $947 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 78 out of 100 for Mark Taafel for performance year 2024, reported as part of a group. Mark Taafel accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Mark Taafel from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $19.